Can Anal Cytology Be a Tool in Following Patients Treated for Squamous Cell Carcinoma of the Anus?
This study demonstrated that HSIL was identified cytologically in the surveillance period. There may be utility in using anal cytology to identify HSIL in patients during this period in lieu of the specialized resources required for HRA. This may allow dysplasia to be treated with excision and fulguration prior to redevelopment of SCCA.PMID:35258352 | DOI:10.1177/00031348221080426 (Source: The American Surgeon)
Source: The American Surgeon - March 8, 2022 Category: Surgery Authors: Benjamin Brasseur Oswaldo Subillaga Matthew Vrees Adam Klipfel Leslie Roth Steven Schechter Source Type: research
Vulvar High-Grade Squamous Intraepithelial Lesions and Cancer as a Risk Factor for Anal Cancer: A Review
Conclusions
Clinicians need be aware that women with vHSIL and VSCC comprise one of the highest-risk groups for ASCC. Inquiring suggestive symptoms of ASCC and a digital anorectal examination can help in the early detection of this type of cancer. (Source: Journal of Lower Genital Tract Disease)
Source: Journal of Lower Genital Tract Disease - December 23, 2021 Category: OBGYN Tags: HPV Associated Disease Source Type: research
Progression of Anal Intraepithelial Neoplasia to Cancer Is Low with Anoscopy Surveillance and Treatment
(Source: Journal of Gastrointestinal Surgery)
Source: Journal of Gastrointestinal Surgery - November 9, 2021 Category: Surgery Source Type: research
The other side of screening: predictors of treatment and follow-up for anal precancers in a large health system
Discussion:
Even in large specialized anal cancer screening programs adherence to HSIL treatment and surveillance is low. Psychosocial and economic determinants of health may impact retention in care. Addressing both personal and structural barriers to patient engagement may improve the effectiveness of anal cancer screening. (Source: AIDS)
Source: AIDS - October 12, 2021 Category: Infectious Diseases Tags: CONCISE COMMUNICATIONS Source Type: research
What Are We Waiting for? —Start Screening High-risk Individuals for Anal Cancer Now—Reply
In Reply We thank Terlizzi et al for their comments on our cohort study and insightful review of the current literature, which highlights the importance of anal dysplasia screening in high-risk individuals and the subsequent treatment of high-grade lesions to prevent the progression to anal cancer. We agree with their impassioned call to begin screening for and treating high-grade anal dysplasia in at-risk populations to address the alarming rise in anal cancer incidence in the US. However, we encourage clinicians to use a shared decision-making model with their patients given the lack of the highest-quality evidence on an...
Source: JAMA Dermatology - September 29, 2021 Category: Dermatology Source Type: research
What Are We Waiting for? —Start Screening High-risk Individuals for Anal Cancer Now
To the Editor We were delighted to read the cohort study by Arnold et al that found an association between anogenital warts (AGW) and increased anal cancer (AC) rates in people living with HIV (PLHIV) (4.4% vs 0.3%; P < .001). Raising awareness among clinicians is important given the rising rates of AC. The authors concluded that PLHIV with AGW need counseling for increased AC risk but stopped short of recommending screening, citing a lack of evidence and few clinicians trained in high-resolution anoscopy (essen tially colposcopy of the anal canal). Anal cancer is similar to cervical cancer in human papillomavirus...
Source: JAMA Dermatology - September 29, 2021 Category: Dermatology Source Type: research
Sapi Med Colorectal Anoscopes and Proctoscopes
No abstract available (Source: Biomedical Safety and Standards)
Source: Biomedical Safety and Standards - August 27, 2021 Category: Medical Devices Tags: RECALLS & FIELD CORRECTIONS—CLASS II Source Type: research
HPV vaccination to prevent recurrence of anal intraepithelial neoplasia in HIV+ MSM
Conclusion:
Despite adequate serological responses to qHPV vaccination, short-term recurrence of HGAIN was not prevented. These findings do not support qHPV vaccination as a treatment adjuvant to prevent HGAIN recurrence in HIV+ MSM. (Source: AIDS)
Source: AIDS - August 9, 2021 Category: Infectious Diseases Tags: CLINICAL SCIENCE Source Type: research
Prevalence of Abnormal Anal Cytology in Women with Abnormal Cervical Cytology
CONCLUSION: Prevalence of abnormal anal cytology was 5.5% in patients with abnormal cervical cytology. The prevalence might be support anal cytology screening in this group of patients.PMID:34319039 | DOI:10.31557/APJCP.2021.22.7.2165 (Source: Asian Pacific Journal of Cancer Prevention)
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2021 Category: Cancer & Oncology Authors: Perapong Inthasorn Nuthchamon Wetpithayakom Somsak Laiwejpithaya Varut Lohsiriwat Attapon Jaishuen Boonlert Viriyapak Source Type: research
